| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |